Tenet Healthcare (NYSE:THC) Announces Earnings Results

Thursday, July 22, 2021 | MarketBeat

Tenet Healthcare (NYSE:THC) posted its earnings results on Tuesday. The company reported $1.59 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.07 by $0.52, MarketWatch Earnings reports. The firm had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.78 billion. Tenet Healthcare had a net margin of 2.25% and a return on equity of 65.38%. The firm's revenue for the quarter was up 35.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.26 EPS.

Shares of THC opened at $70.00 on Thursday. The company has a market cap of $7.48 billion, a P/E ratio of 19.37 and a beta of 2.61. Tenet Healthcare has a 52-week low of $21.34 and a 52-week high of $73.65. The company has a current ratio of 1.36, a quick ratio of 1.28 and a debt-to-equity ratio of 14.86. The company has a fifty day simple moving average of $66.97.

In other Tenet Healthcare news, EVP Howard Hacker sold 6,382 shares of the business's stock in a transaction dated Friday, May 28th. The stock was sold at an average price of $66.70, for a total value of $425,679.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider R. Scott Ramsey sold 8,662 shares of the business's stock in a transaction dated Friday, May 14th. The shares were sold at an average price of $64.04, for a total value of $554,714.48. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 21,197 shares of company stock valued at $1,371,540. 1.60% of the stock is currently owned by corporate insiders.

THC has been the subject of several recent analyst reports. lifted their price objective on shares of Tenet Healthcare from $58.00 to $65.00 in a research report on Thursday, April 22nd. Barclays lifted their target price on Tenet Healthcare from $55.00 to $62.00 in a research note on Friday, April 23rd. Zacks Investment Research downgraded Tenet Healthcare from a "buy" rating to a "hold" rating and set a $72.00 price target on the stock. in a research note on Tuesday, June 22nd. Mizuho lifted their price objective on Tenet Healthcare from $55.00 to $70.00 and gave the stock a "buy" rating in a report on Wednesday, May 5th. Finally, Seaport Global Securities started coverage on Tenet Healthcare in a report on Friday, July 9th. They issued a "buy" rating and a $80.00 price target for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the stock. Tenet Healthcare presently has a consensus rating of "Buy" and an average target price of $57.50.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Read More: What is a Call Option?

Earnings History for Tenet Healthcare (NYSE:THC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Tenet Healthcare right now?

Before you consider Tenet Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.

While Tenet Healthcare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.